Design, synthesis and molecular docking of novel structural hybrids of substituted isatin based pyrazoline and thiadiazoline as antitumor agents
作者:Kiran Gangarapu、Gouthami Thumma、Sarangapani Manda、Anvesh Jallapally、Ravi Jarapula、Sriram Rekulapally
DOI:10.1007/s00044-017-1781-5
日期:2017.4
,3′-pyrazol]-2-one derivatives (20–24) as potent anticancer agents. These compounds were evaluated for in vitro antitumor activity against the National Cancer Institute panel of 60 cancer cell lines. Among all the synthesized compounds, two compounds 15 and 16 showed remarkable antitumor activity with GI50 (MG-MID) values of 0.65 & 0.72 µM, respectively against Non-small cell lung cancer. To gain insight
癌症,被认为是世界上最严重的疾病,导致820万人死亡,并且到2030年这一比率可能翻一番。我们在此报告了一系列新的3-(2-(p-取代)-2-((5-苯基- -1,3,4-噻二唑-2-基)亚氨基)-2-(对-取代的)亚乙基)二氢吲哚-2-酮(15 - 19)和5-取代的5'-取代的苯基-2',4'二氢螺[二氢吲哚-3,3'-吡唑] -2-酮衍生物(20 - 24)作为有效的抗癌剂。评估了这些化合物对60个癌细胞系的国家癌症研究所的体外抗肿瘤活性。在所有合成的化合物中,两种化合物15和16对GI 50均显示出显着的抗肿瘤活性非小细胞肺癌的(MG-MID)值分别为0.65和0.72 µM。为了深入了解与表皮生长因子受体激酶酶的结合方式,对这些化合物进行了进一步的对接研究。